Search

everythinglearnresearchcommunity

for

Search:↓

The most common hair loss type at specialist clinics is androgenetic alopecia, especially in younger men, followed by alopecia areata and telogen effluvium, with differences seen across regions.

Men with enlarged prostates often have more severe baldness.

Chemotherapy often causes patterned hair loss, with some scalp areas more resistant to hair loss than others.

Reduced AR gene methylation may cause early pubic hair growth in girls.

Low-dose oral minoxidil effectively improves male hair loss with mild side effects.

COVID-19 infection may cause significant hair loss, but full hair recovery is likely without special treatment.

Polymeric micelle nanocarriers deliver adapalene more effectively to hair follicles than commercial products.

Anti-androgens, like finasteride, dutasteride, and spironolactone, may lessen the severity of COVID-19 in men, leading to fewer ICU admissions.

A new method for delivering drugs through the skin using biodegradable particles was found to be effective.

Valproic acid may help hair grow and could be a safe treatment for hair loss.

Androgenetic alopecia linked to COVID-19 severity; drugs reducing androgen receptor activation may help.

Valproic Acid could potentially be used to treat immune-related conditions due to its ability to modify immune cell functions.

Nude mice with grafted human skin developed scars similar to human hypertrophic scars.

Trichoscopy helps diagnose and assess the severity of Frontal Fibrosing Alopecia.

Premature hair graying in young men is linked to family history, obesity, and smoking.

Botulinum toxin has potential for treating various skin conditions and improving wound healing.

Proxalutamide significantly lowered hospital admissions for male COVID-19 patients compared to a placebo.

Proxalutamide helps COVID-19 patients get rid of the virus faster and recover quicker.

Some treatments for folliculitis decalvans work well, with tetracyclines and a mix of rifampicin and clindamycin being most effective.

COVID-19 patients often experience hair loss and scalp pain, which may be related to the severity of their infection and treatment drugs.

Low-dose oral minoxidil safely treats hair loss, with hypertrichosis as main side effect.

Valproic acid increases hair count in men with hair loss.

5-alpha-reductase inhibitors may reduce COVID-19 symptoms in bald males.

Most Korean systemic lupus erythematosus patients experienced hair loss, often as non-scarring diffuse hair loss, with non-scarring patch alopecia also common.

Hair loss from COVID-19 usually starts around 45 days after infection and lasts about 47.5 days.

AGA linked to worse COVID-19 outcomes in men.

In Brazil in 2018, the most common skin issues were acne, photoaging, and nonmelanoma skin cancer, with treatments often including topical medications and sunscreen.

Finasteride effectively treats hair loss in transgender men with few side effects.

Temporal triangular alopecia is a non-scarring hair loss in children, often linked to other health conditions.

Combining laser hair removal with topical eflornithine is recommended for better results in treating unwanted facial hair.